After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

PORT-OF-SPAIN, Trinidad (AP) — The prime minister of Trinidad and Tobago retracted comments where she asserted that no U.S. Marines were currently in the twin-island nation — a development that comes ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Like its predecessor, “Wicked: For Good” more than doubles the runtime of Act II of the Broadway musical that inspired it. But unlike the first “Wicked” film, the sequel makes big additions to the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

Frankenstein was first published over 200 years ago, but Mary Shelley's Gothic novel has more than stood the test of time. Many adaptations have been made for stage and screen in the two centuries ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Denver Broncos head coach Sean Payton is walking back his clear jab at New York Giants quarterback Russell Wilson, his former colleague. Payton was asked about Wilson's clap back on X from Tuesday, in ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...